Suppression of apoptosis by overexpression of Bcl-2 or Bcl-x(L) promotes survival and mutagenesis after oxidative damage

Biochimie

Volumn 79, Issue 9-10, 1997, Pages 613-617

  Cherbonnel Lasserre, C ^a,b   Dosanjh, M K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

Apoptosis; Bcl 2; Bcl x(L); H2O2; Mutagenesis; Oxidative damage

Indexed keywords

CYTOPLASM PROTEIN; HYDROGEN PEROXIDE; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; MUTAGENESIS; OXIDATIVE STRESS;

EID: 0031467933     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(97)82011-1     Document Type: Conference Paper

References (36)

1. Wyllie AH, Kerr JFR, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68, 251-307
2. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462
3. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124, 1-6
4. Hanada M, Aime-Sampe C, Sato T, and Reed JC (1995). Structure-function analysis of Bcl-2 protein. J Biol Chem 270, 11962-11965
5. Vaux DL, Cory S, Adams JM (1988) bcl-2 gene promotes haemopoeitic cell survival and cooperates with c-myc to immortalize preB-cells. Nature 335, 440-442
6. Fukunaga-Johnson N, Ryan JJ, Wicha M, Nuñez G, Clarke MF (1995) Bcl-2 protects murine erythroleukemia cells from p53-dependent and -independent radiation-induced cell death. Carcinogenesis 16, 1761-1767
7. L and Bcl-2 repress a common pathway of cell death. J Exp Med 182, 821-828
8. L in the control of apoptosis in murine myeloma cell. Cancer Res 56, 1451-1456
9. L. Cancer Res 56, 1621-1628
10. Tsujimoto Y, Croce C (1986) Cloning of the chromosome breakpoint of neoplastic B-cell with the t (14;18) translocation. Proc Natl Acad Sci USA 83, 5214-5218
11. Strasser A, Harris AW, Bath ML, Cory S (1990). Novel primitive lymphoid tumors induced in a transgenic mice by cooperation between myc and bcl-2. Nature 348, 331-333
12. Hockenbery DM, Nuñez G, Milliman C, Shriber D, Korsmeyer. SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336
13. Sentman CL, Shutter JR, Hockenbery. D, Kanagawa O, Korsmeyer SJ (1991) Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67, 879-888
14. Miyashita T, Reed JC (1992). Bcl-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Camcer Res 52, 5407-5411
15. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A (1993) Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B-cells from programmed cell death. Proc Natl Acad Sci USA 90, 8479-8483
16. L. Nature 374, 811-813
17. L but not Bcl-2. Proc Natl Acad Sci USA 91, 7350-7354
18. L is expressed in neuroblastoma cells and modulated chelotherapy-induced apoptosis. Cancer Res 55, 2576-2582
19. Chen G, Branton PE, Shore GC (1995) Induction of p53-independent apoptosis by hydromycin B: suppression by Bcl-2 and adenovirus E1B 19-kDa protein. Exp Cell Res 221, 55-59
20. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-616
21. L, a bcl-2 related gene that functions as a dominat regulator of apoptotic cell death. Cell 74, 597-608
22. Yin XM, Oltvai ZN, Korsmeyer SJ (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369, 321-323
23. L promotes susceptibility to mutagenesis. Oncogene 13, 1489-1497
24. Xia F, Wang X, Wang YH, Tsang NM, Yandell DW, Kelsey KT, Liber HL (1995) Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblastoid lines. Cancer Res 55, 12-15
25. Liber HL, Thilly WG (1982) Mutation assay at the thymidine kinase locus in diploid human lymphoblasts. Mutat Res 94, 467-485
26. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63
27. Furth EE, Thilly WG, Penman BW, Liber HL, Rand WM (1981) Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. Anal Biochem 110, 1-8
28. Korsmeyer SJ (1992). Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol 10, 785-807
29. Strasser A, Harris AW, Jacks T, Cory S (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79, 329-339
30. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainshi MA, Bradley A, Donehower LA (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8, 2457-2467
31. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell-cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89, 7491-7495
32. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849
33. Bakalkin G, Yakovleva T, Selivanova G, Magnusson KP, Szekely L, Kiselva E, Klein G, Terenius L, Wiman KG (1994) p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc Natl Acad Sci USA 91, 413-417
34. Linette GP, Hess JL, Sentman CL, Korsmeyer SJ (1995) Peripheral T-cell lymphoma in Ickpr-bcl-2 transgenic mice. Blood 86, 1255-1260
35. Strasser A, Harris AW, Bath ML, Cory S (1990) Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature 348, 331-333
36. Liu Y, Naumovski L, Hanawalt P (1997) Nucleotide excision repair capacity is attenuated in human promyelocytic HL60 cells that over-express Bcl-2. Cancer Res 57, 1650-1653